Cerevel Therapeutics Hldg (NASDAQ:CERE) reported its Q2 earnings results on Monday, August 1, 2022 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Cerevel Therapeutics Hldg missed estimated earnings by 27.08%, reporting an EPS of $-0.61 versus an estimate of $-0.48.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 9.08% drop in the share price the next day.
To track all earnings releases for Cerevel Therapeutics Hldg visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
